Select a medication above to begin.
Jatenzo
testosterone undecanoate
Black Box Warnings .
Blood Pressure Increases
only indicated in male pts w/ hypogonadal conditions assoc. w/ structural or genetic etiologies; may cause incr. BP that may incr. risk of major adverse cardiovascular events, incl. non-fatal MI, non-fatal stroke, and cardiovascular death; greater risk in pts w/ cardiovascular risk factors or established CVD; consider baseline cardiovascular risks and control BP prior to tx start; monitor BP 3wk after tx start or dose incr, then periodically and treat new-onset HTN or exacerbations of pre-existing HTN; weigh tx benefits vs. risks in pts who develop cardiovascular risk factors or CVD while on tx
Adult Dosing .
Dosage forms: CAP: 158 mg, 198 mg, 237 mg
primary hypogonadism, male
- [158-396 mg PO bid]
- Start: 237 mg PO bid; Max: 792 mg/day; Info: adjust dose based on testosterone levels; give w/ food
hypogonadotropic hypogonadism, male
- [158-396 mg PO bid]
- Start: 237 mg PO bid; Max: 792 mg/day; Info: adjust dose based on testosterone levels; give w/ food
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [not defined]
Peds Dosing .
Peds dosing is currently unavailable or not applicable for this drug.